Objective: Colorectal cancer screening program using fecal immunochemical test had been conducted on an isolated island named Nii-jima. However, the participation rate of the program had been approximately 12%, which was lower than average level of Japan. This study aimed to evaluate the participation rate, safety and efficacy of a colorectal cancer screening program using colonoscopy on the island. Methods: Educational campaigns were actively conducted every month using information bulletins and special propaganda pamphlets. The primary recommended modality was colonoscopy, followed by fecal immunochemical test. The participants of this program were 1671 individuals aged 40-79 years (men, 819; women, 852). Results: A total of 789 (47.2%) individuals provided consent for this screening program, and 89.2% (704/789) of participants chose colonoscopy as the primary screening procedure. The completion rate of total colonoscopy was 99.7%, and there was no complication during this program. Detection rates of invasive cancer, intramucosal cancer, advanced neoplasia and any adenoma were 0.9% (n = 6), 2.4% (n = 17), 11.8% (n = 83) and 50.0% (n = 352), respectively. The adenoma detection rate and incidence of advanced neoplasia were significantly higher in men than in women in all age groups. Conclusions: The colorectal cancer screening program using colonoscopy that was conducted on an island achieved considerably higher participation rate than the conventional screening program using fecal immunochemical test. Completion rate and safety of screening colonoscopy were excellent during this program.
Introduction
Recently, colorectal cancer (CRC) is the leading cause of cancerrelated deaths among female gender and the third most common cause of death among both genders in Japan (1) . Screening test may play an extremely important role for suppression of CRC deaths. Fecal occult bold test has a rigid evidence for reduction of CRC deaths from multiple randomized controlled trials (2) (3) (4) (5) . At present, national screening program using 2-day fecal immunochemical testing (FIT) has been conducted for the population aged 40 years or older in Japan (6) . However, the participation rate of the screening program had been limited in 20% range. Moreover, the undergoing rate of colonoscopy for participants with positive for FIT had been limited in 60% range. Application of the nationwide program using FIT in Japan will leave much room for improvement. However, some countries introduce screening total colonoscopy (TCS) for nationwide program (7) . TCS has a high sensitivity for detection of CRC and advanced neoplasia, so effectiveness of suppressing CRC death will be expected greater than other tests. At the present time, TCS has not been used in a national screening program for CRC in Japan. We conducted a prospective CRC screening program on an isolated island (Niijima), which is a part of Tokyo Metropolis, with a population of 3068 individuals (men, 1,485; women, 1,583). Few years before our trial, the participation rate of a CRC screening program conducted on this island that used FIT had been approximately 10-12%. This study aimed to evaluate the participation rate, safety and efficacy of a CRC screening program using TCS.
Patients and methods
The Institutional Review Board of National Cancer Center Hospital (Tokyo, Japan) approved the study protocol. Educational campaigns were conducted for 1 year before recruitment. The primary recommended modality was TCS, followed by FIT. The participants of this program were 1671 individuals aged 40-79 years (men, 819; women, 852). All participants in the island were Japanese. Endoscopic equipment was set up at the health center (Sawayaka Kenko Center) in Nii-jima, and 21 endoscopists performed screening using colonoscopy. All endoscopists had experienced more than 1000 colonoscopies before this trial. Primary end point was the participation rate of our program. A landmark of participation rate was setting as 50% including all screening tests. Participation rate was calculated with those of either TCS or FIT. Secondary end points were detection rates and characteristics of colorectal neoplasms, and safety of colonoscopy. Informed consent about complications of colonoscopy was obtained from all participants before examination. All costs of examinations in this study were not charged for each participant.
Educational campaigns for screening
Educational campaigns were actively conducted every month using information bulletins for all residents (1 page per month, 12 times) of the island and special propaganda pamphlets (A5 × 8 pages) about CRC screening for 1 year before recruitment. These contents were created by the primary investigator (T.M.) and described about epidemiology of CRC, efficacy of screening test and details of screening tests including FIT and TCS. Creating cost of one pamphlet was about 50 JPY (≅ 0.5 USD).
Fecal immunochemical testing
Quantitative FIT (OC-sensor System; Eiken Chemical) was used with 100 ng hemoglobin/ml buffer as cutoff (equivalent to 20 μg hemoglobin/g), and all subjects were asked to submit two fecal samples.
Total colonoscopy
All patients received 2-3 l of polyethylene glycol solution or 1.8-2.4 l of magnesium citrate solution in the morning of the procedure day.
Endoscopic system was consisted by EVIS LUCERA 260 (Olympus Co., Tokyo, Japan). All examinations were performed by magnifying video colonoscopies (CF-H260AZI, PCF-Q240ZI; Olympus Co.). Narrow band imaging (NBI) or chromoendoscopy with 0.2% indigo carmine dye with magnification could be routinely used for diagnosis of detected lesions. Scopolamine butyl bromide (20 mg) was administered intravenously for suppressing bowel movement, unless contraindicated. If necessary, the conscious sedation was maintained with intravenous boluses of midazolam.
Management of colorectal neoplasms
During initial screening colonoscopic examinations in this study, only optical diagnoses with magnified endoscopy using NBI or chromoendoscopy were performed. Endoscopic resections of colorectal neoplasms were not conducted in initial screening TCS. If colorectal neoplasm larger than 5 mm or advanced neoplasia was detected, endoscopic removal or surgical resection was indicated. The participants were treated at the National Cancer Center Hospital within 6 months after screening colonoscopy. Therefore, colorectal neoplasms smaller than 5 mm were basically left and optically diagnosed without pathology.
Calculation of detected lesions
Diagnosis of adenoma was based on optical diagnosis using magnified endoscopy. Colorectal neoplasm larger than 5 mm or advanced neoplasia was confirmed by pathological diagnosis obtained from endoscopic remove or surgical resection. Invasive cancer was defined as cancer invading into submucosal layer or deeper. Advanced neoplasia was defined as adenoma with 10mm or larger in size, highgrade adenoma, intramucosal cancer and invasive cancer. Detection rate of any adenoma was calculated by all adenomas, intramucosal cancer and invasive cancer.
Statistical analysis
Participation rates and detection rates were compared in each category by using chi-square test. Calculated P values <0.05 were considered statistically significant.
Results
A total of 789 (47.2%) individuals provided consent for this screening program among the 1671 recruited participants between July 2011 and September 2014. Eighty-nine percent (704/789) of individuals chose colonoscopy as the primary screening procedure, and the others chose only FIT (Figure 1) . A proportion of screening participants who had previous experience of colonoscopy and family history of CRC was 33.7% and 11.8%, respectively ( Table 1 ). The participation rate of individuals aged 40-69 years was significantly higher than that of individuals aged 70-79 years (51.2 vs. 35.1%; P < 0.0001) (Figure 2) .
Data of screening colonoscopy in this study included colonoscopy as the first examination (n = 704). The completion rate of TCS was 99.7% (702/704), and there was no major complication during this program. In the two failed patients, cecal intubation was not completed due to a difficult situation. Mean and median of cecal intubation time was 6.4 and 6 minutes, respectively.
Detection rates of invasive cancer, intramucosal cancer, advanced neoplasia, number of adenoma ≥3 size, of adenoma ≥5 mm and any adenoma were 0.9% (n = 6), 2.4% (n = 17), 11.8% (n = 83), 13.9% (n = 98), 26.3% (n = 185) and 50.0% (n = 352), respectively ( Table 2 ). The adenoma detection rate (ADR) (any adenoma, P < 0.001; size of adenoma ≥5 mm, P < 0.001; and number of adenoma ≥3, P < 0.001) and incidence of advanced neoplasia (P < 0.001) were significantly higher in men than in women; however, there was no difference in the incidence of intramucosal cancer (P = 0.06) and invasive cancer (P = 0.9) between men and women.
All patients who had invasive cancer (n = 6) underwent curative surgical resection in the National Cancer Center Hospital. In these six patients, one was diagnosed as T3 and five as T1 according to resected specimen. Moreover, all patients who had intramucosal cancers, advanced neoplasia and adenoma ≥5 mm underwent endoscopic resection without any complication.
Discussion
The present study is the first trial to assess the efficacy of colonoscopy for population-based CRC screening program in Japan. The trial was carried out in an isolated island in which there were no medical institutions conducting endoscopic examination to expect a great deal of our intervention.
There were two important things to evaluate in the study. First was the impact for participating rate of educational campaigns and introduction of a new screening test in the region in which the rate of CRC screening had been inferior to other areas in Japan. FIT could be selective for participants who had been reluctant to receive colonoscopic examinations. Second was to evaluate the feasibility and quality of screening colonoscopy. Accordingly, cecal intubation rate, ADR, CRC detection rate and complications were analyzed.
The participation rate improved to approximately 50%, occupied 89% by colonoscopy. Before our intervention, the participation rate of CRC screening in the island had been at a lower level of approximately 10% during the recent few years. This rate had been lower than whole Tokyo Metropolis and whole Japan. However, participation rates of the present intervention were approximately 50% during the 3 years.
In the present intervention, campaign of CRC screening was conducted using information bulletins for all residents of the island and special propaganda pamphlets about CRC screening by printed mail. Today, the Internet and media are widely used for calling of cancer screening. However, these were not necessarily popular in elderly people. In contrast, information bulletins were certainly read by all residents in the local region and costs of producing them were not expensive. Therefore, these calling methods were expected as a great deal of effectiveness for all generations. Our previous Asian international study revealed that physician recommendation and knowledge of screening tests were significant predictors of CRC test uptake (8) . Our campaign might be effective to increase knowledge of CRC screening test for the originally low participation area.
Some countries conducted organized colon cancer screening as a nationwide program (6, 7, (9) (10) (11) (12) . In Asian countries, Taiwan and Japan had taken FIT as colon cancer screening. CRC screening using FIT conducted within a multiple disease screening in a part of Taiwan (Keelung) was reported (13) . Their overall attendance rate and compliance of colonoscopy were very high (10) . They simulated that multiple disease screening program was cost-effective than for single disease screening. Moreover, they emphasized the importance of manpower including social worker volunteers and student volunteers and public commercial with media and television containing health education message (13) . In Japan, nationwide CRC screening program supported by the government using 2-day FIT had started in 1992 (6). All residents aged 40 years or older can attend the screening. However, the participation rate of FIT and compliance of colonoscopy had been at low rates. Furthermore, feedback system of effectiveness of screening program had not been satisfactorily organized yet. Therefore, mortality reduction of CRC in Japan has not been realized yet. Screening TCS and polypectomy was considered to be effective for the reduction of CRC deaths from some case-control cohort studies (14, 15) . However, there was no randomized controlled trial for this subject.
Some countries had already introduced colonoscopy for nationwide screening program. In Germany, screening TCS program had started in 2002 and the cumulative participation rate during 6 years was 17.2% of eligible women and 15.5% of eligible men (7). Their result was valuable, because invited participants covered 90% of the general population and collected detailed colonoscopic results with pathology.
Inadomi et al. reported that participation rate for screening TCS which they can select only was lower than the choice of fecal occult blood test or TCS based on the result of a randomized trial (16) . Our results proved this point of view. We previously announced about specific information, so proportion of participants selecting TCS were significantly more than selecting only FIT. Moreover, free charge of screening test and high experience of attending endoscopists were possible to increase the participation rate.
Another knowledge obtained from present study was feasibility and quality of screening colonoscopy. All colonoscopic examinations without polypectomy were operated safely including bowel preparation and premedication. Cecal intubation rate was extremely higher than recommended level by a US recommendation (17) . ADR demonstrated a high level as 50% in comparison with the recommended target (17) . Furthermore, advanced neoplasia and cancer were detected at a high level among screening setting at average risk participants.
There were few acknowledge of ADR of the Asian average risk populations. In Taiwan's prospective study including 1708 patients, ADR and advanced neoplasia detection rate of average risk patients was 15.4% and 3.0%, respectively (18) . The present results demonstrated extremely high ADR (50.0%) and detection rate of advanced neoplasia (11.8%). Based on the early results of a Spanish randomized controlled study, detection rate of advanced adenoma and nonadvanced adenoma in colonoscopy-based screening were significantly higher than FIT in spite of the similar detection rate of invasive cancer (19) . Cost of colonoscopy-based CRC screening simulated in the Japanese setting is slightly higher than FIT to detect one CRC patient (20) . However, detected CRC in colonoscopy-based screening stage are earlier than FIT, thereby total costs of treatments might be reduced. Moreover, achievement of higher ADR was demonstrated to lead to cost-effectiveness in a US setting (21) .
The biggest advantage of screening colonoscopy is the ability to stratify individual risk of CRC in a screening examination. Definitive evidence of screening colonoscopy will be decided from ongoing randomized trials (19, 22) .
Limitations of this study were specific study field, small participant number, only expert endoscopists, free charge to participants and absence of pathology of diminutive polyps.
In conclusion, the CRC screening program using colonoscopy that was conducted on an island achieved considerably higher participation rate than the conventional screening program using FIT. Completion rate and safety of screening colonoscopy were excellent during this program.
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